Medicare makes changes to coverage of controversial Alzheimer’s drug Aduhelm
According to CNN article published April 7th, 2022 “Medicare will restrict coverage of the controversial and costly Alzheimer’s drug Aduhelm to those enrolled in qualifying clinical trials,…
